Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Feb 15;99(4):608–617. doi: 10.1172/JCI119203

Prevention of bleomycin-induced pulmonary fibrosis after adenovirus-mediated transfer of the bacterial bleomycin resistance gene.

P L Tran 1, J Weinbach 1, P Opolon 1, G Linares-Cruz 1, J P Reynes 1, A Grégoire 1, E Kremer 1, H Durand 1, M Perricaudet 1
PMCID: PMC507842  PMID: 9045862

Abstract

A serious limitation in the use of the DNA-cleaving, antitumoral-antibiotic, bleomycin during chemotherapy is pulmonary toxicity. Lung injury induced by bleomycin is characterized by an increased deposition of interstitial extracellular matrix proteins in the alveolar wall that compromises respiratory function. Several drugs have been tested in animal models to prevent the pulmonary toxicity of bleomycin, but have not led to a useful clinical treatment because of their adverse effects on other tissues. We have shown that transgenic mice expressing Streptoalloteichus hindustanus (Sh) ble bleomycin resistance protein in pulmonary epithelial cells in the lungs are protected against bleomycin-induced toxicity in lungs. In the present study, we used intranasal administration by adenovirus-mediated gene transfer of the bleomycin resistance Sh ble gene to mouse lung for prevention of bleomycin-induced pulmonary fibrosis. We constructed recombinant adenoviruses Ad.CMVble and Ad.RSVble harboring the bleomycin resistance Sh ble gene under the control of the cytomegalovirus early promoter and the Rous sarcoma virus early promoter, respectively. Transgene expression was detected in epithelia of conducting airways and alveolar septa by immunostaining with a rabbit polyclonal antibody directed against the bleomycin resistance protein and persisted for the duration of drug treatment; i.e., up to 17 d. No toxic effect was seen in adenovirus-treated mice. Pretreatment of mice with Ad.CMVble or Ad.RSVble completely prevented collagen deposition 42-133 d after bleomycin treatment, as measured by lung OH-proline content. Histologic studies indicated that there was little or no lung injury in the adenovirus/bleomycin-treated mice compared with the bleomycin-treated mice. These observations may lead to new approaches for the prevention of bleomycin-induced pulmonary fibrosis.

Full Text

The Full Text of this article is available as a PDF (706.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson I. Y., Bowden D. H. The pathogenesis of bleomycin-induced pulmonary fibrosis in mice. Am J Pathol. 1974 Nov;77(2):185–197. [PMC free article] [PubMed] [Google Scholar]
  2. Bedrossian C. W., Luna M. A., Mackay B., Lichtiger B. Ultrastructure of pulmonary bleomycin toxicity. Cancer. 1973 Jul;32(1):44–51. doi: 10.1002/1097-0142(197307)32:1<44::aid-cncr2820320106>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  3. Bennett J. M., Reich S. D. Bleomycin. Ann Intern Med. 1979 Jun;90(6):945–948. doi: 10.7326/0003-4819-90-6-945. [DOI] [PubMed] [Google Scholar]
  4. Bitterman P. B., Rennard S. I., Adelberg S., Crystal R. G. Role of fibronectin as a growth factor for fibroblasts. J Cell Biol. 1983 Dec;97(6):1925–1932. doi: 10.1083/jcb.97.6.1925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Blum R. H., Carter S. K., Agre K. A clinical review of bleomycin--a new antineoplastic agent. Cancer. 1973 Apr;31(4):903–914. doi: 10.1002/1097-0142(197304)31:4<903::aid-cncr2820310422>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  6. Brody S. L., Metzger M., Danel C., Rosenfeld M. A., Crystal R. G. Acute responses of non-human primates to airway delivery of an adenovirus vector containing the human cystic fibrosis transmembrane conductance regulator cDNA. Hum Gene Ther. 1994 Jul;5(7):821–836. doi: 10.1089/hum.1994.5.7-821. [DOI] [PubMed] [Google Scholar]
  7. Calmels T. P., Mistry J. S., Watkins S. C., Robbins P. D., McGuire R., Lazo J. S. Nuclear localization of bacterial Streptoalloteichus hindustanus bleomycin resistance protein in mammalian cells. Mol Pharmacol. 1993 Dec;44(6):1135–1141. [PubMed] [Google Scholar]
  8. Colby T. V., Churg A. C. Patterns of pulmonary fibrosis. Pathol Annu. 1986;21(Pt 2):277–309. [PubMed] [Google Scholar]
  9. Collins J. F., McCullough B., Coalson J. J., Johanson W. G., Jr Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. II. Further studies on connective tissue changes. Am Rev Respir Dis. 1981 Mar;123(3):305–312. doi: 10.1164/arrd.1981.123.3.305. [DOI] [PubMed] [Google Scholar]
  10. Cooper J. A., Jr, White D. A., Matthay R. A. Drug-induced pulmonary disease. Part 1: Cytotoxic drugs. Am Rev Respir Dis. 1986 Feb;133(2):321–340. doi: 10.1164/arrd.1986.133.2.321. [DOI] [PubMed] [Google Scholar]
  11. Dong J. Y., Wang D., Van Ginkel F. W., Pascual D. W., Frizzell R. A. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum Gene Ther. 1996 Feb 10;7(3):319–331. doi: 10.1089/hum.1996.7.3-319. [DOI] [PubMed] [Google Scholar]
  12. Drocourt D., Calmels T., Reynes J. P., Baron M., Tiraby G. Cassettes of the Streptoalloteichus hindustanus ble gene for transformation of lower and higher eukaryotes to phleomycin resistance. Nucleic Acids Res. 1990 Jul 11;18(13):4009–4009. doi: 10.1093/nar/18.13.4009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dumas P., Bergdoll M., Cagnon C., Masson J. M. Crystal structure and site-directed mutagenesis of a bleomycin resistance protein and their significance for drug sequestering. EMBO J. 1994 Jun 1;13(11):2483–2492. doi: 10.1002/j.1460-2075.1994.tb06535.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gatignol A., Durand H., Tiraby G. Bleomycin resistance conferred by a drug-binding protein. FEBS Lett. 1988 Mar 28;230(1-2):171–175. doi: 10.1016/0014-5793(88)80665-3. [DOI] [PubMed] [Google Scholar]
  15. Giri S. N., Hyde D. M., Hollinger M. A. Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax. 1993 Oct;48(10):959–966. doi: 10.1136/thx.48.10.959. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Graham F. L., Smiley J., Russell W. C., Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977 Jul;36(1):59–74. doi: 10.1099/0022-1317-36-1-59. [DOI] [PubMed] [Google Scholar]
  17. Harrison J. H., Jr, Lazo J. S. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis. J Pharmacol Exp Ther. 1987 Dec;243(3):1185–1194. [PubMed] [Google Scholar]
  18. Herz J., Gerard R. D. Adenovirus-mediated transfer of low density lipoprotein receptor gene acutely accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci U S A. 1993 Apr 1;90(7):2812–2816. doi: 10.1073/pnas.90.7.2812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hoyt D. G., Lazo J. S. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther. 1988 Aug;246(2):765–771. [PubMed] [Google Scholar]
  20. Hussar D. A. New drugs of 1973. Am J Pharm Sci Support Public Health. 1974 Mar-Apr;146(2):37–58. [PubMed] [Google Scholar]
  21. Ichikawa T., Nakano I., Hirokawa I. Bleomycin treatment of the tumors of penis and scrotum. J Urol. 1969 Dec;102(6):699–707. doi: 10.1016/s0022-5347(17)62235-3. [DOI] [PubMed] [Google Scholar]
  22. Jaffe H. A., Danel C., Longenecker G., Metzger M., Setoguchi Y., Rosenfeld M. A., Gant T. W., Thorgeirsson S. S., Stratford-Perricaudet L. D., Perricaudet M. Adenovirus-mediated in vivo gene transfer and expression in normal rat liver. Nat Genet. 1992 Aug;1(5):372–378. doi: 10.1038/ng0892-372. [DOI] [PubMed] [Google Scholar]
  23. Kass-Eisler A., Falck-Pedersen E., Elfenbein D. H., Alvira M., Buttrick P. M., Leinwand L. A. The impact of developmental stage, route of administration and the immune system on adenovirus-mediated gene transfer. Gene Ther. 1994 Nov;1(6):395–402. [PubMed] [Google Scholar]
  24. King S. L., Lichtler A. C., Rowe D. W., Xie R., Long G. L., Absher M. P., Cutroneo K. R. Bleomycin stimulates pro-alpha 1 (I) collagen promoter through transforming growth factor beta response element by intracellular and extracellular signaling. J Biol Chem. 1994 May 6;269(18):13156–13161. [PubMed] [Google Scholar]
  25. Kovacs E. J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today. 1991 Jan;12(1):17–23. doi: 10.1016/0167-5699(91)90107-5. [DOI] [PubMed] [Google Scholar]
  26. Kovacs E. J., Kelley J. Intra-alveolar release of a competence-type growth factor after lung injury. Am Rev Respir Dis. 1986 Jan;133(1):68–72. doi: 10.1164/arrd.1986.133.1.68. [DOI] [PubMed] [Google Scholar]
  27. Kremer E. J., Perricaudet M. Adenovirus and adeno-associated virus mediated gene transfer. Br Med Bull. 1995 Jan;51(1):31–44. doi: 10.1093/oxfordjournals.bmb.a072951. [DOI] [PubMed] [Google Scholar]
  28. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  29. Lazo J. S. Angiotensin converting enzyme activity in mice after subacute bleomycin administration. Toxicol Appl Pharmacol. 1981 Jun 30;59(2):395–404. doi: 10.1016/0041-008x(81)90211-8. [DOI] [PubMed] [Google Scholar]
  30. Lazo J. S., Hoyt D. G., Sebti S. M., Pitt B. R. Bleomycin: a pharmacologic tool in the study of the pathogenesis of interstitial pulmonary fibrosis. Pharmacol Ther. 1990;47(3):347–358. doi: 10.1016/0163-7258(90)90061-6. [DOI] [PubMed] [Google Scholar]
  31. Lazo J. S., Humphreys C. J. Lack of metabolism as the biochemical basis of bleomycin-induced pulmonary toxicity. Proc Natl Acad Sci U S A. 1983 May;80(10):3064–3068. doi: 10.1073/pnas.80.10.3064. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Linares-Cruz G., Millot G., De Cremoux P., Vassy J., Olofsson B., Rigaut J. P., Calvo F. Combined analysis of in situ hybridization, cell cycle and structural markers using reflectance and immunofluorescence confocal microscopy. Histochem J. 1995 Jan;27(1):15–23. doi: 10.1007/BF00164168. [DOI] [PubMed] [Google Scholar]
  33. Moseley P. L., Hemken C., Hunninghake G. W. Augmentation of fibroblast proliferation by bleomycin. J Clin Invest. 1986 Nov;78(5):1150–1154. doi: 10.1172/JCI112695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Muggia F. M., Louie A. C., Sikic B. I. Pulmonary toxicity of antitumor agents. Cancer Treat Rev. 1983 Dec;10(4):221–243. doi: 10.1016/0305-7372(83)90012-9. [DOI] [PubMed] [Google Scholar]
  35. Mulsant P., Gatignol A., Dalens M., Tiraby G. Phleomycin resistance as a dominant selectable marker in CHO cells. Somat Cell Mol Genet. 1988 May;14(3):243–252. doi: 10.1007/BF01534585. [DOI] [PubMed] [Google Scholar]
  36. Piguet P. F., Rosen H., Vesin C., Grau G. E. Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am Rev Respir Dis. 1993 Feb;147(2):435–441. doi: 10.1164/ajrccm/147.2.435. [DOI] [PubMed] [Google Scholar]
  37. Piguet P. F., Vesin C. Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice. Eur Respir J. 1994 Mar;7(3):515–518. doi: 10.1183/09031936.94.07030515. [DOI] [PubMed] [Google Scholar]
  38. Quinones F., Crouch E. Biosynthesis of interstitial and basement membrane collagens in pulmonary fibrosis. Am Rev Respir Dis. 1986 Dec;134(6):1163–1171. doi: 10.1164/arrd.1986.134.6.1163. [DOI] [PubMed] [Google Scholar]
  39. Raap A. K., van de Corput M. P., Vervenne R. A., van Gijlswijk R. P., Tanke H. J., Wiegant J. Ultra-sensitive FISH using peroxidase-mediated deposition of biotin- or fluorochrome tyramides. Hum Mol Genet. 1995 Apr;4(4):529–534. doi: 10.1093/hmg/4.4.529. [DOI] [PubMed] [Google Scholar]
  40. Ragot T., Vincent N., Chafey P., Vigne E., Gilgenkrantz H., Couton D., Cartaud J., Briand P., Kaplan J. C., Perricaudet M. Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature. 1993 Feb 18;361(6413):647–650. doi: 10.1038/361647a0. [DOI] [PubMed] [Google Scholar]
  41. Reiser K. M., Last J. A. Early cellular events in pulmonary fibrosis. Exp Lung Res. 1986;10(4):331–355. doi: 10.3109/01902148609058286. [DOI] [PubMed] [Google Scholar]
  42. Rosenfeld M. A., Yoshimura K., Trapnell B. C., Yoneyama K., Rosenthal E. R., Dalemans W., Fukayama M., Bargon J., Stier L. E., Stratford-Perricaudet L. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell. 1992 Jan 10;68(1):143–155. doi: 10.1016/0092-8674(92)90213-v. [DOI] [PubMed] [Google Scholar]
  43. Shenk T., Williams J. Genetic analysis of adenoviruses. Curr Top Microbiol Immunol. 1984;111:1–39. doi: 10.1007/978-3-642-69549-0_1. [DOI] [PubMed] [Google Scholar]
  44. Stratford-Perricaudet L. D., Levrero M., Chasse J. F., Perricaudet M., Briand P. Evaluation of the transfer and expression in mice of an enzyme-encoding gene using a human adenovirus vector. Hum Gene Ther. 1990 Fall;1(3):241–256. doi: 10.1089/hum.1990.1.3-241. [DOI] [PubMed] [Google Scholar]
  45. Stratford-Perricaudet L. D., Makeh I., Perricaudet M., Briand P. Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest. 1992 Aug;90(2):626–630. doi: 10.1172/JCI115902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Tran P. L., Deugnier M. A. Intracellular localization of 12-O-3-N-dansylamino TPA in C3H/10T1/2 mouse cell line. Carcinogenesis. 1985 Mar;6(3):433–439. doi: 10.1093/carcin/6.3.433. [DOI] [PubMed] [Google Scholar]
  47. Umezawa H., Maeda K., Takeuchi T., Okami Y. New antibiotics, bleomycin A and B. J Antibiot (Tokyo) 1966 Sep;19(5):200–209. [PubMed] [Google Scholar]
  48. Van Doren K., Gluzman Y. Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants. Mol Cell Biol. 1984 Aug;4(8):1653–1656. doi: 10.1128/mcb.4.8.1653. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Van Doren K., Hanahan D., Gluzman Y. Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA. J Virol. 1984 May;50(2):606–614. doi: 10.1128/jvi.50.2.606-614.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES